Clinical Trials Directory

Trials / Completed

CompletedNCT04908904

Acute Effects of Cafestol on Glucose Metabolism in Subjects With Type-2-diabetes.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Acute, double-blinded, randomized, cross-over cafestol intervention study with sixteen participants with T2D participating in two OGTTs.

Detailed description

The study is an acute, double-blinded, randomized, cross-over intervention study with sixteen participants with T2D. Initially, a blood sample is obtained (t=-15 min) and at time point 0, the participants will ingest a tablet containing either 12 mg cafestol or placebo. Immediately hereafter an OGTT commences with ingestion of a 75 g glucose solution. In the following 3 hours blood samples are collected at time points 0, 15, 30, 60, 90, 120 and 180 min. The samples will be used for determination of plasma glucose, insulin and cafestol, as well as GLP-1 and GIP. After a one-week washout period, the subject will undergo the same set-up again, however now with the opposite intervention / placebo.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCafestolCapsule with 12 mg cafestol
DIETARY_SUPPLEMENTPlaceboPlacebo capsule without cafestol

Timeline

Start date
2021-05-27
Primary completion
2022-02-16
Completion
2022-02-16
First posted
2021-06-01
Last updated
2022-02-28

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04908904. Inclusion in this directory is not an endorsement.

Acute Effects of Cafestol on Glucose Metabolism in Subjects With Type-2-diabetes. (NCT04908904) · Clinical Trials Directory